{"nct_id":"NCT02609776","title":"Study of Amivantamab, a Human Bispecific EGFR and cMet Antibody, in Participants With Advanced Non-Small Cell Lung Cancer","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2016-05-24","start_date_type":"ACTUAL","primary_completion_date":"2026-12-31","primary_completion_date_type":"ESTIMATED","completion_date":"2026-12-31","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["JNJ"]}